文献速递脊髓损伤康复神经康复

脊髓损伤后运动训练中机器人外骨骼预算影响分析:四家SCI模型系统数据

Budget impact analysis of robotic exoskeleton use for locomotor training following spinal cord injury in four SCI Model Systems.
PubMed 文献 · J Neuroeng Rehabil · 2020-01-10

该研究基于四家脊髓损伤模型系统康复医院2017年数据,开展预算影响分析,比较在现有运动训练策略中加入机器人外骨骼地面训练的成本影响。基础案例分析显示,机器人外骨骼地面训练降低医院运动训练成本,每年净节省1114至4784美元,但结果对参数假设敏感,概率敏感性分析下仅一家机构仍具成本节约。

要点

  • 基础案例分析中,加入机器人外骨骼地面训练可降低运动训练年成本,净节省1114至4784美元。
  • 结果对临床利用参数(如设备闲置频率、高成本训练替代)比设备本身参数更敏感。
  • 概率敏感性分析同时考虑人力资本成本、设备成本和设备替代后,仅一家机构仍保持成本节约。

核心结论

  • 基础案例分析中,提供机器人外骨骼地面训练与脊髓损伤患者运动训练成本降低相关。
  • 该分析对参数假设敏感,概率敏感性分析下仅一家机构仍具成本节约。

研究设计与样本

  • 预算影响分析(BIA),使用四家脊髓损伤模型系统康复医院提供的数据。
  • 医院提供2017年参与运动训练的脊髓损伤患者的治疗利用和成本估计。

主要发现

  • 基础案例分析中,机器人外骨骼地面训练降低医院运动训练成本。
  • 每年10%的运动训练 sessions(范围226-397次)使用机器人外骨骼地面训练,年运动训练成本净节省1114至4784美元。
  • 基础案例节省较小,对BIA模型参数敏感,通过单因素敏感性分析、情景分析和概率敏感性分析检验。
  • 基础案例情景对临床利用参数(如设备闲置频率和高成本训练替代)比设备特定参数(如设备成本或寿命)更敏感。
  • 概率敏感性分析同时考虑人力资本成本、设备成本和运动设备替代,仅一家机构引入机器人外骨骼仍保持成本节约。

关键数值与推荐

  • 干预措施包括标准护理步行训练:体重支持跑台训练、地面训练、固定式机器人系统(即跑台机器人步态矫形器)和地面机器人外骨骼训练。
  • 主要结局指标包括设备成本、人员使用设备的培训成本、运动训练的人力资本成本、设备需求和每位脊髓损伤患者的训练次数。

临床怎么用

  • 在基础案例分析假设下,将机器人外骨骼地面训练整合入运动训练可能降低医院成本。
  • 成本节约受临床利用参数影响较大,需关注设备使用率和训练替代模式。

局限性

  • 分析假设不同运动训练策略的干预效果无差异。
  • 结果对参数假设敏感,概率敏感性分析下仅一家机构仍具成本节约。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We know little about the budget impact of integrating robotic exoskeleton over-ground training into therapy services for locomotor training. The purpose of this study was to estimate the budget impact of adding robotic exoskeleton over-ground training to existing locomotor training strategies in the rehabilitation of people with spinal cord injury. METHODS: A Budget Impact Analysis (BIA) was conducted using data provided by four Spinal Cord Injury (SCI) Model Systems rehabilitation hospitals. Hospitals provided estimates of therapy utilization and costs about people with spinal cord injury who participated in locomotor training in the calendar year 2017. Interventions were standard of care walking training including body-weight supported treadmill training, overground training, stationary robotic systems (i.e., treadmill-based robotic gait orthoses), and overground robotic exoskeleton training. The main outcome measures included device costs, training costs for personnel to use the device, human capital costs of locomotor training, device demand, and the number of training sessions per person with SCI. RESULTS: Robotic exoskeletons for over-ground training decreased hospital costs associated with delivering locomotor training in the base case analysis. This analysis assumed no difference in intervention effectiveness across locomotor training strategies. Providing robotic exoskeleton overground training for 10% of locomotor training sessions over the course of the year (range 226-397 sessions) results in decreased annual locomotor training costs (i.e., net savings) between $1114 to $4784 per annum. The base case shows small savings that are sensitive to parameters of the BIA model which were tested in one-way sensitivity analyses, scenarios analyses, and probability sensitivity analyses. The base case scenario was more sensitive to clinical utilization parameters (e.g., how often devices sit idle and the substitution of high cost training) than device-specific parameters (e.g., robotic exoskeleton device cost or device life). Probabilistic sensitivity analysis simultaneously considered human capital cost, device cost, and locomotor device substitution. With probabilistic sensitivity analysis, the introduction of a robotic exoskeleton only remained cost saving for one facility. CONCLUSIONS: Providing robotic exoskeleton for over-ground training was associated with lower costs for the locomotor training of people with SCI in the base case analyses. The analysis was sensitive to parameter assumptions.

来源:J Neuroeng Rehabil,查看原文。版权归原作者所有。

引用

  1. Pinto D, Garnier M, Barbas J, et al. Budget impact analysis of robotic exoskeleton use for locomotor training following spinal cord injury in four SCI Model Systems. J Neuroeng Rehabil. 2020. PMID: 31924224. doi:10.1186/s12984-019-0639-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。